Bio-Techne Corp (TECH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Techne Corp (TECH) has a cash flow conversion efficiency ratio of 0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($86.66 Million) by net assets ($2.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TECH net asset quality index to measure how much of total assets are equity-financed.
Bio-Techne Corp - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Bio-Techne Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bio-Techne Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Bio-Techne Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Techne Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Webster Financial Corporation
NYSE:WBS
|
0.033x |
|
Leonardo DRS, Inc. Common Stock
NASDAQ:DRS
|
-0.024x |
|
Mowi ASA
OL:MOWI
|
0.199x |
|
LG Corp
KO:003550
|
0.009x |
|
WOORI FIN. GRP SP.ADR/3
F:2WGA
|
0.311x |
|
ALTEOGEN Inc
KQ:196170
|
0.041x |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
0.075x |
|
HudBay Minerals Inc
TO:HBM
|
0.052x |
Annual Cash Flow Conversion Efficiency for Bio-Techne Corp (1990–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Techne Corp from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bio-Techne Corp.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $1.92 Billion | $287.56 Million | 0.150x | +3.70% |
| 2024-06-30 | $2.07 Billion | $298.98 Million | 0.145x | +11.71% |
| 2023-06-30 | $1.97 Billion | $254.39 Million | 0.129x | -32.35% |
| 2022-06-30 | $1.70 Billion | $325.27 Million | 0.191x | -14.68% |
| 2021-06-30 | $1.57 Billion | $352.16 Million | 0.224x | +50.85% |
| 2020-06-30 | $1.38 Billion | $205.22 Million | 0.149x | -4.65% |
| 2019-06-30 | $1.17 Billion | $181.62 Million | 0.156x | -1.30% |
| 2018-06-30 | $1.08 Billion | $170.37 Million | 0.158x | +4.64% |
| 2017-06-30 | $950.83 Million | $143.45 Million | 0.151x | -7.80% |
| 2016-06-30 | $879.28 Million | $143.87 Million | 0.164x | -0.56% |
| 2015-06-30 | $846.93 Million | $139.36 Million | 0.165x | -4.32% |
| 2014-06-30 | $795.26 Million | $136.76 Million | 0.172x | +2.65% |
| 2013-06-30 | $737.54 Million | $123.56 Million | 0.168x | -10.85% |
| 2012-06-30 | $674.44 Million | $126.75 Million | 0.188x | -13.40% |
| 2011-06-30 | $586.12 Million | $127.19 Million | 0.217x | -2.13% |
| 2010-06-30 | $501.79 Million | $111.26 Million | 0.222x | -9.08% |
| 2009-06-30 | $456.48 Million | $111.32 Million | 0.244x | +3.02% |
| 2008-06-30 | $487.13 Million | $115.32 Million | 0.237x | +14.48% |
| 2007-06-30 | $437.65 Million | $90.50 Million | 0.207x | -17.77% |
| 2006-06-30 | $340.35 Million | $85.59 Million | 0.251x | -9.50% |
| 2005-06-30 | $267.87 Million | $74.43 Million | 0.278x | +26.07% |
| 2004-06-30 | $297.43 Million | $65.55 Million | 0.220x | -3.58% |
| 2003-06-30 | $236.62 Million | $54.09 Million | 0.229x | +70.63% |
| 2002-06-30 | $206.52 Million | $27.67 Million | 0.134x | -48.67% |
| 2001-06-30 | $177.66 Million | $46.37 Million | 0.261x | -4.90% |
| 2000-06-30 | $141.15 Million | $38.74 Million | 0.274x | -6.45% |
| 1999-06-30 | $96.80 Million | $28.40 Million | 0.293x | -7.79% |
| 1998-06-30 | $63.80 Million | $20.30 Million | 0.318x | +22.44% |
| 1997-06-30 | $48.10 Million | $12.50 Million | 0.260x | +3.15% |
| 1996-06-30 | $38.90 Million | $9.80 Million | 0.252x | +1.81% |
| 1995-06-30 | $29.50 Million | $7.30 Million | 0.247x | -9.66% |
| 1994-06-30 | $23.00 Million | $6.30 Million | 0.274x | +8.35% |
| 1993-06-30 | $17.80 Million | $4.50 Million | 0.253x | -27.40% |
| 1992-06-30 | $11.20 Million | $3.90 Million | 0.348x | +21.88% |
| 1991-06-30 | $6.30 Million | $1.80 Million | 0.286x | +19.48% |
| 1990-06-30 | $4.60 Million | $1.10 Million | 0.239x | -- |
About Bio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various asp… Read more